Explore the impact of Real World Evidence (RWE) on healthcare decision-making among regulators, payers, and patients throughout the Asia-Pacific region. With emerging AI applications, evolving reimbursement policies, and new strategies in rare disease research, pharmaceutical companies must adapt to leverage RWE effectively. This virtual conference will explore key developments and best practices to integrate RWE into decision-making across diverse healthcare landscapes.
Our Real-World Evidence offerings turn diverse healthcare data into actionable insights, empowering confident decisions and better patient outcomes.
IQVIA is using vast quantities of data in powerful new ways. See how we can help you tap into information from past trials, patient reported outcomes and other sources to accelerate your research.
